IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v12y2021i1d10.1038_s41467-021-23460-x.html
   My bibliography  Save this article

Rationally designed bacterial consortia to treat chronic immune-mediated colitis and restore intestinal homeostasis

Author

Listed:
  • Daniel Lelie

    (Gusto Global LLC)

  • Akihiko Oka

    (University of North Carolina at Chapel Hill
    Shimane University Faculty of Medicine)

  • Safiyh Taghavi

    (Gusto Global LLC)

  • Junji Umeno

    (University of North Carolina at Chapel Hill
    Kyushu University)

  • Ting-Jia Fan

    (Gusto Global LLC)

  • Katherine E. Merrell

    (Gusto Global LLC)

  • Sarah D. Watson

    (Gusto Global LLC)

  • Lisa Ouellette

    (Gusto Global LLC)

  • Bo Liu

    (University of North Carolina at Chapel Hill)

  • Muyiwa Awoniyi

    (University of North Carolina at Chapel Hill)

  • Yunjia Lai

    (University of North Carolina at Chapel Hill)

  • Liang Chi

    (University of North Carolina at Chapel Hill)

  • Kun Lu

    (University of North Carolina at Chapel Hill)

  • Christopher S. Henry

    (Gusto Global LLC)

  • R. Balfour Sartor

    (University of North Carolina at Chapel Hill)

Abstract

Environmental factors, mucosal permeability and defective immunoregulation drive overactive immunity to a subset of resident intestinal bacteria that mediate multiple inflammatory conditions. GUT-103 and GUT-108, live biotherapeutic products rationally designed to complement missing or underrepresented functions in the dysbiotic microbiome of IBD patients, address upstream targets, rather than targeting a single cytokine to block downstream inflammation responses. GUT-103, composed of 17 strains that synergistically provide protective and sustained engraftment in the IBD inflammatory environment, prevented and treated chronic immune-mediated colitis. Therapeutic application of GUT-108 reversed established colitis in a humanized chronic T cell-mediated mouse model. It decreased pathobionts while expanding resident protective bacteria; produced metabolites promoting mucosal healing and immunoregulatory responses; decreased inflammatory cytokines and Th-1 and Th-17 cells; and induced interleukin-10-producing colonic regulatory cells, and IL-10-independent homeostatic pathways. We propose GUT-108 for treating and preventing relapse for IBD and other inflammatory conditions characterized by unbalanced microbiota and mucosal permeability.

Suggested Citation

  • Daniel Lelie & Akihiko Oka & Safiyh Taghavi & Junji Umeno & Ting-Jia Fan & Katherine E. Merrell & Sarah D. Watson & Lisa Ouellette & Bo Liu & Muyiwa Awoniyi & Yunjia Lai & Liang Chi & Kun Lu & Christo, 2021. "Rationally designed bacterial consortia to treat chronic immune-mediated colitis and restore intestinal homeostasis," Nature Communications, Nature, vol. 12(1), pages 1-17, December.
  • Handle: RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-23460-x
    DOI: 10.1038/s41467-021-23460-x
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-021-23460-x
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1038/s41467-021-23460-x?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Rémi Le Guern & Teddy Grandjean & Sarah Stabler & Marvin Bauduin & Philippe Gosset & Éric Kipnis & Rodrigue Dessein, 2023. "Gut colonisation with multidrug-resistant Klebsiella pneumoniae worsens Pseudomonas aeruginosa lung infection," Nature Communications, Nature, vol. 14(1), pages 1-12, December.
    2. Matthias Bec & Sylvain Pouzet & Céline Cordier & Simon Barral & Vittore Scolari & Benoit Sorre & Alvaro Banderas & Pascal Hersen, 2024. "Optogenetic spatial patterning of cooperation in yeast populations," Nature Communications, Nature, vol. 15(1), pages 1-14, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-23460-x. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.